Skip to main content

Table 3 Overall response

From: Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer

Best response

nab-PTX plus RAM

PTX plus RAM

P value

N = 83

%

N = 106

%

CR

0

0

0

0

 

PR

28

33.7

29

27.4

SD

40

48.2

42

39.6

PD

11

13.3

28

26.4

NE

4

4.8

7

6.6

ORR

28

33.7

29

27.4

0.385

DCR

68

81.9

71

67

0.016

  1. nab-PTX nanoparticle albumin-bound paclitaxel, RAM ramucirumab, CR complete response, PR partial response, SD stable disease, PD progressive disease, NE not evaluated, ORR overall response rate, DCR disease control rate
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us